Novavax, Inc. - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Novavax provides update conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Silvia Taylor. Please go ahead.
Thank you, and good afternoon, everyone. Thank you for joining today's call and webcast. Earlier today, we issued a press release announcing top line data results from our recent Phase III trial in the U.K. and Phase IIb trial in South Africa. That press release is available on our website at novavax.com as our slides we will be using during this afternoon's call. An audio archive of this call will also be available on our website later today.
Before we begin, I need to remind you that we will be making forward-looking statements during this teleconference that could include financial, clinical or commercial projections. Statements relating to future financial or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |